- CDTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Cidara Therapeutics (CDTX) S-3Shelf registration
Filed: 20 May 16, 12:00am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectuses of Cidara Therapeutics, Inc. for the registration of its common stock and to the incorporation by reference therein of our report dated March 18, 2016, with respect to the financial statements of Cidara Therapeutics, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2015, to be filed with the Securities and Exchange Commission on or about May 19, 2016.
/s/ Ernst & Young
San Diego, CA
May 19, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.